Skip to main content
. 2017 Mar 15;9(3):910–925.

Figure 1.

Figure 1

Exogenous aFGF (0.5 μg/g) administration improves neurofunctional deficits 24 h after experimental TBI in C57BL/6 mice. A. Representative effects of aFGF on EB extravasation. B. Summary data showing EB extravasation fluorescence. C. aFGF-treated mice performed differently on the garcia test than vehicle-treated mice. D. FITC-dextran fluorescence 24 h after TBI. *P < 0.05 versus sham group. **P < 0.01 versus sham group. #P < 0.05 versus TBI group. Data are presented as the mean ± standard error of the mean. n = 6.